Quarterly
Annual
| Unit: USD | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue: | |||||||||||||||||||||||
sale of copiktra license and related assets | 649,000 | ||||||||||||||||||||||
total revenue | 2,596,000 | 545,000 | 2,000 | 500,000 | 1,006,000 | 506,000 | 78,647,000 | 4,307,000 | 5,056,000 | 3,616,000 | 9,032,000 | 3,136,000 | 1,671,000 | 1,210,000 | 15,508,000 | 10,000,000 | |||||||
yoy | 158.05% | 7.71% | -100.00% | -88.39% | -80.10% | -86.01% | 770.76% | 37.34% | 202.57% | 198.84% | -41.76% | -68.64% | |||||||||||
qoq | 376.33% | 27150.00% | -99.60% | -50.30% | 98.81% | -99.36% | 1726.03% | -14.81% | 39.82% | -59.96% | 188.01% | 87.67% | 38.10% | -92.20% | 55.08% | ||||||||
operating expenses: | |||||||||||||||||||||||
research and development | 10,924,000 | 12,456,000 | 12,219,000 | 11,346,000 | 9,758,000 | 8,762,000 | 11,571,000 | 12,381,000 | |||||||||||||||
selling, general and administrative | 7,363,000 | 7,399,000 | 7,329,000 | 6,106,000 | 6,421,000 | 6,514,000 | 5,934,000 | 5,660,000 | 5,523,000 | 6,714,000 | 6,218,000 | 7,095,000 | 20,614,000 | 15,442,000 | 19,604,000 | 23,728,000 | 22,153,000 | 29,298,000 | 26,033,000 | 26,199,000 | 25,426,000 | ||
total operating expenses | 21,309,000 | 20,292,000 | 19,344,000 | 16,846,000 | 17,709,000 | 21,402,000 | 19,576,000 | 17,056,000 | 14,848,000 | 16,444,000 | 15,114,000 | 17,260,000 | 63,630,000 | 25,571,000 | 31,415,000 | 36,908,000 | 35,135,000 | 41,413,000 | 36,341,000 | 35,469,000 | 37,077,000 | 28,194,000 | |
income from operations | -21,309,000 | -20,292,000 | -19,344,000 | -16,846,000 | -17,709,000 | -21,402,000 | -16,980,000 | -16,511,000 | -14,846,000 | -15,944,000 | -14,108,000 | -16,754,000 | 15,017,000 | -21,264,000 | -26,359,000 | -33,292,000 | -26,103,000 | -38,277,000 | -34,670,000 | -34,259,000 | -21,569,000 | -18,194,000 | |
yoy | 20.33% | -5.19% | 13.92% | 2.03% | 19.28% | 34.23% | 20.36% | -1.45% | -198.86% | -25.02% | -46.48% | -49.68% | -157.53% | -44.45% | -23.97% | -2.82% | 21.02% | 110.38% | |||||
qoq | 5.01% | 4.90% | 14.83% | -4.87% | -17.26% | 26.04% | 2.84% | 11.22% | -6.89% | 13.01% | -15.79% | -211.57% | -170.62% | -19.33% | -20.82% | 27.54% | -31.81% | 10.40% | 1.20% | 58.83% | 18.55% | ||
operating margin % | -654.08% | -3029.54% | -742300.00% | -3188.80% | -1402.39% | -3311.07% | 19.09% | -493.71% | -521.34% | -920.69% | -289.01% | -1220.57% | -2074.81% | -2831.32% | -139.08% | -181.94% | |||||||
other income | -1,313,000 | ||||||||||||||||||||||
interest income | 2,247,000 | 1,122,000 | 976,000 | 111,500 | 316,000 | 84,000 | 46,000 | 40,000 | 40,000 | 49,000 | 52,000 | 18,000 | 19,000 | 122,000 | 356,000 | 611,000 | 1,005,000 | 1,268,000 | 1,497,000 | 1,306,000 | 763,000 | 343,000 | |
interest expense | -1,129,000 | -1,121,000 | -769,000 | -724,000 | -717,000 | -640,000 | -56,000 | -10,000 | -7,980,000 | -1,007,000 | -975,000 | -1,354,000 | -1,898,000 | -1,868,000 | -10,674,000 | -5,452,000 | -5,041,000 | -5,185,000 | -4,929,000 | -3,952,000 | -862,000 | -516,000 | |
change in fair value of preferred stock tranche liability | |||||||||||||||||||||||
net income | -20,004,000 | -24,281,000 | -15,714,000 | -16,808,000 | -18,090,000 | -21,952,000 | -16,962,000 | -16,481,000 | -22,786,000 | -16,902,000 | -15,031,000 | -19,864,000 | 13,138,000 | -23,010,000 | -37,990,000 | -38,774,000 | -30,139,000 | -42,194,000 | -38,102,000 | -11,349,000 | -21,668,000 | -18,367,000 | |
yoy | 10.58% | 10.61% | -7.36% | 1.98% | -20.61% | 29.88% | 12.85% | -17.03% | -273.44% | -26.54% | -60.43% | -48.77% | -143.59% | -45.47% | -0.29% | 241.65% | 39.09% | 129.73% | |||||
qoq | -17.61% | 54.52% | -6.51% | -7.09% | -17.59% | 29.42% | 2.92% | -27.67% | 34.81% | 12.45% | -24.33% | -251.20% | -157.10% | -39.43% | -2.02% | 28.65% | -28.57% | 10.74% | 235.73% | -47.62% | 17.97% | ||
net income margin % | -653.39% | -3024.04% | -1139300.00% | -3380.40% | -1494.14% | -3925.69% | 16.71% | -534.25% | -751.38% | -1072.29% | -333.69% | -1345.47% | -2280.19% | -937.93% | -139.72% | -183.67% | |||||||
net income per share | -0.75 | -1.37 | -0.08 | -0.075 | -0.09 | -0.12 | -0.09 | -0.078 | -0.13 | -0.1 | -0.09 | -0.12 | 0.08 | -0.14 | -0.35 | -0.51 | -0.41 | -0.57 | -0.52 | -0.13 | -0.29 | -0.3 | |
| |||||||||||||||||||||||
weighted-average common shares outstanding used in computing net income per share—basic and diluted | 74,228 | 73,877 | 73,854 | ||||||||||||||||||||
unrealized gain on available-for-sale securities | 48 | -5 | 6 | 39 | 91 | -17 | 5 | 53 | -9 | -13 | -59 | -24 | -17 | 125 | 4 | ||||||||
comprehensive loss | -19,956 | -24,286 | -15,708 | -16,769 | -17,999 | -21,969 | -17,109 | -16,897 | -15,050 | -19,811 | 13,138 | -23,019 | -37,995 | -38,787 | -30,198 | -42,218 | -38,119 | -11,224 | -21,670 | -18,363 | |||
transition services revenue | |||||||||||||||||||||||
unrealized loss on available-for-sale securities | -147 | -19 | |||||||||||||||||||||
product revenue | 134,000 | 5,829,000 | 4,235,000 | 5,034,000 | 3,617,000 | 4,032,000 | 3,019,000 | 1,671,000 | 1,210,000 | 508,000 | |||||||||||||
license and collaboration revenue | 22,000 | -1,000 | 5,000,000 | 117,000 | |||||||||||||||||||
cost of sales - product | 495,000 | 332,000 | 371,000 | 377,000 | |||||||||||||||||||
cost of sales - intangible amortization | 392,000 | 392,000 | 392,000 | 392,000 | |||||||||||||||||||
cost of sales - sale of copiktra license and related assets | |||||||||||||||||||||||
weighted-average common shares outstanding used in computing: | |||||||||||||||||||||||
unrealized (loss) on available-for-sale securities | -6.5 | -12 | |||||||||||||||||||||
comprehensive income | -13,686.25 | -22,798 | |||||||||||||||||||||
weighted-average common shares outstanding used in computing net income per share - basic and diluted | 108,153 | ||||||||||||||||||||||
costs of revenues, excluding amortization of acquired intangible assets | 158,000 | 116,000 | 49,000 | ||||||||||||||||||||
amortization of acquired intangible assets | 392,000 | 392,000 | 31,000 | ||||||||||||||||||||
license revenue | 15,000,000 | 10,000,000 | |||||||||||||||||||||
weighted-average number of common shares used in net income per share—basic and diluted | 73,644 | 61,256 | |||||||||||||||||||||
general and administrative | 15,813,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.